Manage Your Liver
Q:

World Hepatitis Day 2016 - Harm reduction is possible!

World Hepatitis Day 2016 - Harm reduction is possible!
A:

World Hepatitis Day 2016 is just around the corner (on July 28), aiming to boost global awareness on hepatitis, this year’s campaign is “Elimination” which can be achieved through universal vaccination, enhanced blood and injection safety, as well as harm reduction and treatment [1].

 

Controlling or eliminating the hepatitis virus has always been regarded as the only way to treat hepatitis. When patients are diagnosed with hepatitis, antiviral treatment is the only option. However, drugs are not able to repair damaged liver cells or normalize liver function. This results in a lack of focus on harm reduction and recovery during the process. In fact, how to effectively reduce injury is essential to preventing the situation from worsening, as only stopping inflammation can reduce the chance of developing other serious liver diseases.

 

Therefore, among the promotional contents of WHD 2016, “harm reduction” should be the primary concern. So what can patients do to reduce injury in everyday life?

 

To reduce injury, patients should first tackle the problem with utmost urgency, which is to stop inflammation in the liver and maintain normal ALT. When inflammation stops, it implies that the liver cells are no longer injured, and damage to the liver can be greatly reduced. [2][3] Therefore, patients should focus on how to stop inflammation early in order to reduce injury.

 

One treatment option that matches this concept is ‘ALT Focused Therapy’. This approach focuses on reducing patients’ injury, overcoming the limitations and shortcomings of the current treatment. ‘ALT Focused Therapy’ can help patients significantly reduce the time with liver injury through rapid recovery of liver cells and opposing inflammation.

 

Find out more about ‘ALT Focused Therapy

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Chronic liver disease is a serious condition and a leading cause of death among people across the world. The number of liver cancer cases have over took to become the leading cancer since 2014, and fatty liver disease/ NASH is set to become the leading cause of liver transplant in 2020. Protects your liver In the view of this, liver protection to prevent chronic liver disease is quickly becoming more important then ever. So what can we do
A:
ALT and AST are enzymes that are normally predominantly contained within liver cells. If the liver is injured or damaged, the liver cells spill these enzymes into the blood, raising the AST and ALT enzyme levels in the blood, and we can use it as a measurement of liver injury.   What are the differences between ALT and AST? AST is normally found in a variety of tissues including liver, heart, muscle, kidney, and the brain. It is released int
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us